← Back
$HIMS All transactions

Hims & Hers Health, Inc.

▼ SELL 10b5-1 Plan

$ Value

$954K

Shares

17,729

Price

$54

Filed

Sep 17

Insider

Name

Dudum Andrew

Title

Chief Executive Officer

CIK

0001837796

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2025-09-16

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

210,425

Footnotes

The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. | The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. | The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.01 - $54.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $52.45 - $53.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $53.435 - 54.30. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $53.38 - $54.30. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $53.37 - $54.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $52.62 - $53.60. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $53.62 - $54.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $53.62 - $54.30. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025. | Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. | The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.

Filing Info

Accession No.

0001773751-25-000301

Form Type

4

Issuer CIK

0001773751

Dudum Andrew's History

Date Ticker Type Value
2026-04-09 HIMS G
2026-04-09 HIMS G
2026-03-13 HIMS F $10.8M
2026-03-13 HIMS M
2026-03-13 HIMS F $2.2M
2026-03-13 HIMS M $0
2026-03-13 HIMS M $0
2026-03-13 HIMS M $0
2026-03-13 HIMS M $0
2026-03-11 HIMS A $0

Other Insiders at HIMS (90d)

Insider Bought Sold Last
Dudum Andrew
Chief Executive Officer
2026-04-09
Boughton Soleil
Chief Legal Officer
$473K 2026-04-20
Carroll Patrick Harrison
Chief Medical Officer
2026-03-13
Autor Deborah M.
Chief Policy Officer
2026-03-13
Becklund Irene
PAO
$137K 2026-03-17
Okupe Oluyemi
Chief Financial Officer
$2.5M 2026-04-20
Chi Michael
Chief Operating Officer
$2.4M 2026-03-17
Pendarvis Christiane 2026-03-13
Elshenawy Mohamed
CTO
2026-03-11